Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1592-1597

  Własiuk, Paulina ^a   Tomczak, Waldemar ^a   Zajac, Małgorzata ^a   Dmoszyńska, Anna ^a   Giannopoulos, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; TOLL LIKE RECEPTOR 9;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; MALE; PRIORITY JOURNAL;

CHRONIC LYMPHOCYTIC LEUKEMIA; CLL; CPG ODN; CPG OLIGODEOXYNUCLEOTIDES; DC; DENDRITIC CELLS; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FBS; FETAL BOVINE SERUM; HEALTHY VOLUNTEERS; HV; IL; INTERLEUKIN; MAJOR HISTOCOMPATIBILITY COMPLEX; MEAN FLUORESCENCE INTENSITY; MFI; MHC; NATURAL KILLER CELLS; NK; PAMPS; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; PBMC; PBS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHOSPHATE BUFFERED SALINE; REGULATORY T CELLS; SHLA-G; SOLUBLE HLA-G; TFS; TLR-9; TLRS; TNF; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TREATMENT-FREE SURVIVAL; TREG; TUMOR NECROSIS FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL MEMBRANE; FEMALE; HLA-G ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84888198543     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.277     Document Type: Article

References (26)

1. Ghia P., Chiorazzi N., Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 2008, 264:549-562.
2. Elliott R.L., Jiang X.P., Phillips J.T., Barnett B.G., Head J.F. Human leukocyte antigen G expression in breast cancer: role in immunosuppression. Cancer Biother Radiopharm 2011, 26:153-157.
3. Carosella E.D., Gregori S., LeMaoult J. The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood 2011, 118:6499-6505.
4. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
5. Amiot L., Le Friec G., Sebti Y., Drénou B., Pangault C., Guilloux V., Leleu X., Bernard M., Facon T., Fauchet R. HLA-G and lymphoproliferative disorders. Semin Cancer Biol 2003, 13:379-385.
6. Rebmann V., Nückel H., Dührsen U., Grosse-Wilde H. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications. Semin Cancer Biol 2007, 17:430-435.
7. Giannopoulos K., Schmitt M., Kowal M., Własiuk P., Bojarska-Junak A., Roliński J., et al. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL). Leuk Res 2008, 32:1815-1819.
8. Giannopoulos K., Dmoszyńska A., Bojarska-Junak A., Schmitt M., Roliński J. Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL). Folia Histochem Cytobiol 2008, 46:457-460.
9. Perez-Chacon G., Rosado S., Rebolleda N., Losada-Fernandez I., Vargas J.A., Morado M., et al. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia. Int J Lab Hematol 2009, 31:327-337.
10. Carosella E.D., Gregori S., Rouas-Freiss N., LeMaoult J., Menier C., Favier B. The role of HLA-G in immunity and hematopoiesis. Cell Mol Life Sci 2011, 68:353-368.
11. Le Maux A., Noël G., Birebent B., Grosset J.M., Vu N., De Guibert S., et al. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin Exp Immunol 2008, 152:50-56.
12. Carosella E.D., HoWangYin K.Y., Favier B., LeMaoult J. HLA-G- dependent suppressor cells: diverse by mature, function, and significance. Hum Immunol 2008, 69:700-707.
13. Giannopoulos K., Schmitt M., Kowal M., Wlasiuk P., Bojarska-Junak A., Chen J., et al. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep 2008, 20:677-682.
14. Rozková D., Novotná L., Pytlík R., Hochová I., Kozák T., Bartůnková J., et al. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Int J Cancer 2010, 126:1132-1143.
15. Montero Vega M.T., de Andrés Martín A. The significance of toll-like receptors in human diseases. Allergol Immunopathol 2009, 37:252-263.
16. Grandjenette C., Kennel A., Faure G.C., Béné M.C., Feugier P. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells. Haematologica 2007, 92:1279-1281.
17. Nuckel H., Rebmann V., Durig J., Duhrsen U., Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005, 105:1694-1698.
18. Amiot L., Le Friec G., Sebti Y., et al. HLA-G and lymphoproliferative disorders. Semin Cancer Biol 2003, 13:379-385.
19. Poláková K., Bandzuchová E., Hofmeister V., Weiss E.H., Hutter H., Russ G. Binding analysis of HLA-G specific antibodies to hematopoietic cells isolated from leukemia patients. Neoplasma 2003, 50:331-338.
20. Colonna M., Navarro F., Bellón T., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809-1818.
21. Colonna M., Samaridis J., Cella M., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998, 160:3096-3100.
22. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999, 189:1093-1100.
23. Colonna M., Navarro F., Bellón T., Llano M., García P., Samaridis J., et al. Common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809-1818.
24. Favier B., Lemaoult J., Lesport E., Carosella E.D. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 2010, 24:689-699.
25. Liang X., Moseman E.A., Farrar M.A., Bachanova V., Weisdorf D.J., Blazar B.R., et al. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 2010, 115:5041-5052.
26. Muzio M., Scielzo C., Bertilaccio M.T., Frenquelli M., Ghia P., Caligaris-Cappio F. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Br J Haematol 2009, 144:507-516.